夜尿症与死亡率相关:REDUCE试验观察性数据
基于REDUCE试验中7343名50-75岁男性的观察性分析,基线夜尿(每晚排尿≥3次)与全因死亡率升高独立相关(HR=1.72;95%CI 1.15-2.55),校正人口学及合并症后仍显著;模型加入睡眠障碍后关联减弱(HR=1.43;95%CI 0.93-2.19)。
要点
- 夜尿≥3次/晚与全因死亡率升高独立相关,HR=1.72。
- 校正睡眠障碍后关联减弱且不再显著,提示睡眠中断可能介导。
- 夜尿或需作为独立健康风险因素进行针对性干预。
核心结论
- 夜尿是独立于人口学及合并症的全因死亡率危险因素,但加入睡眠障碍后关联减弱。
研究设计与样本
- REDUCE试验的观察性分析,纳入7343名50-75岁男性,主要来自北美和欧洲。
- 采用Cox比例风险模型检验基线夜尿(≥3次/晚)与全因死亡率的关联。
主要发现
- 夜尿与死亡率升高相关,HR=1.72(95%CI 1.15-2.55),独立于人口学及合并症。
- 模型纳入睡眠障碍后,HR降至1.43(95%CI 0.93-2.19)。
关键数值与推荐
- 夜尿定义为每晚排尿≥3次。
- 混杂变量包括年龄、种族、地区、治疗组、冠心病、糖尿病、高血压、外周血管病、吸烟、饮酒、前列腺体积和利尿剂。
临床怎么用
- 对夜尿≥3次/晚的男性,应关注其死亡风险并考虑针对性干预。
- 评估夜尿时需同时评估睡眠质量,睡眠中断可能是重要中介因素。
局限性
- 研究仅限男性,且半数受试者服用度他雄胺。
- 为观察性分析,无法确立因果关系。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Nocturia (voids arising from sleep) is a ubiquitous phenomenon reflecting many diverse conditions but whether it has significance in its own right remains uncertain. We examined whether nocturia was an independent risk factor for mortality METHODS: These were observational analyses employing primarily North American and European participants and included 7343 men, aged 50-75 years participating in the REDUCE (Reduction by Dutasteride of Prostate Cancer Events) trial. Cox proportional hazards models were used to test the association between baseline nocturia (voiding ≥3 times per night) and all-cause mortality. Potential confounding variables included: age; race; region of origin; treatment group; self-reported coronary artery disease, diabetes mellitus, hypertension, and peripheral vascular disease; smoking; alcohol use; prostate volume; and diuretics. Self-reported sleep quality, as measured with the Medical Outcomes Study sleep scale, was entered as a final step in the model. RESULTS: Nocturia was associated with increased mortality risk (hazard ratio [HR] = 1.72; 95% CI 1.15-2.55) independent from demographics and medical comorbidities. Inclusion of disturbed sleep in the model reduced the magnitude of the association (HR = 1.43; 95% CI 0.93-2.19). CONCLUSIONS: Although the findings are limited to men, half of whom ingested dutasteride, the interruption of sleep by nocturia may have long-term impact on health and may warrant targeted intervention.
引用
- Bliwise DL, Howard LE, Moreira DM, et al. Nocturia and associated mortality: observational data from the REDUCE trial. Prostate Cancer Prostatic Dis. 2018. PMID: 30214036. doi:10.1038/s41391-018-0090-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。